Today Bristol Myers Squibb marks World Hepatitis Day by launching a new campaign in China meant to correct common misperceptions about HCV, and raise awareness about the need for individuals at risk for developing HCV to seek medical advice.
The campaign, designed to help support the World Health Organization’s goal of eliminating hepatitis C in China by 2030, encourages individuals infected with HCV, or those at risk for developing the virus, to “Act Now LIVE betteR” by seeking early screening and diagnosis.
Developed in partnership with the China Association of Health Promotion and Education, the campaign will run until May 2018.
The campaign, designed to help support the World Health Organization’s goal of eliminating hepatitis C in China by 2030, encourages individuals infected with HCV, or those at risk for developing the virus, to “Act Now LIVE betteR” by seeking early screening and diagnosis.
Developed in partnership with the China Association of Health Promotion and Education, the campaign will run until May 2018.
“As leaders in scientific excellence, BMS continues to work to encourage those at risk for developing HCV to seek medical advice and diagnosis,” said Dr. Karl Lintel, President of Bristol Myers Squibb China. “I am proud of the Act now LIVE betteR campaign and all it is doing to raise awareness and help eradicate the stigma attached to HCV.”
